• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical characteristics of patients with uremia undergoing maintenance hemodialysis complicated with COVID-19.维持性血液透析的尿毒症患者合并新型冠状病毒肺炎的临床特征
Medicine (Baltimore). 2020 Aug 7;99(32):e21547. doi: 10.1097/MD.0000000000021547.
2
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.成都 32 例危重症和 67 例非危重症 COVID-19 的流行病学特征和临床特征。
J Clin Virol. 2020 Jun;127:104366. doi: 10.1016/j.jcv.2020.104366. Epub 2020 Apr 10.
3
Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.中国武汉血液透析患者 COVID-19 的临床特征和医学干预措施。
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397. doi: 10.1681/ASN.2020030354. Epub 2020 May 8.
4
Presentation and Outcomes of Patients with ESKD and COVID-19.终末期肾病患者合并 COVID-19 的表现和结局。
J Am Soc Nephrol. 2020 Jul;31(7):1409-1415. doi: 10.1681/ASN.2020040470. Epub 2020 May 28.
5
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.中国武汉维持性血液透析患者 2019 年新型冠状病毒肺炎的临床特征。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1139-1145. doi: 10.2215/CJN.04160320. Epub 2020 May 22.
6
Clinical and radiographic characteristics, management and short-term outcomes of patients with COVID-19 in Wenzhou, China.中国温州地区 COVID-19 患者的临床和影像学特征、治疗方法及短期转归。
BMC Infect Dis. 2020 Nov 13;20(1):841. doi: 10.1186/s12879-020-05528-z.
7
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
8
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
9
Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.分析 136 例新型冠状病毒病患者的临床特征、药物治疗和预后。
J Clin Pharm Ther. 2020 Aug;45(4):609-616. doi: 10.1111/jcpt.13170. Epub 2020 May 25.
10
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020.2020 年湖北省武汉市周边地区 COVID-19 的流行病学和临床特征分析。
Pharmacol Res. 2020 Jul;157:104821. doi: 10.1016/j.phrs.2020.104821. Epub 2020 Apr 30.

引用本文的文献

1
Platelet-albumin-bilirubin score and neutrophil-to-lymphocyte ratio predict intensive care unit admission in patients with end-stage kidney disease infected with the Omicron variant of COVID-19: a single-center prospective cohort study.血小板-白蛋白-胆红素评分和中性粒细胞与淋巴细胞比值预测感染奥密克戎变异株的终末期肾病患者入住重症监护病房:一项单中心前瞻性队列研究。
Ren Fail. 2023 Dec;45(1):2199097. doi: 10.1080/0886022X.2023.2199097.
2
The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review.《COVID-19 大流行时代血液透析患者的脆弱世界:系统范围界定综述》。
J Nephrol. 2021 Oct;34(5):1387-1403. doi: 10.1007/s40620-021-01136-5. Epub 2021 Aug 21.
3
Characteristics and outcomes of hemodialysis patients with COVID-19: a retrospective single center study.新型冠状病毒肺炎血液透析患者的特征与结局:一项回顾性单中心研究
PeerJ. 2020 Nov 26;8:e10459. doi: 10.7717/peerj.10459. eCollection 2020.

本文引用的文献

1
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
2
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
3
[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].[29例2019新型冠状病毒肺炎患者临床特征分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 6;43(0):E005. doi: 10.3760/cma.j.issn.1001-0939.2020.0005.
4
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
5
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Potential for global spread of a novel coronavirus from China.新型冠状病毒可能会从中国向全球传播。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa011.
8
A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs).对接受植入式心脏复律除颤器(ICD)的终末期肾病患者死亡率的荟萃分析。
PLoS One. 2014 Jul 18;9(7):e99418. doi: 10.1371/journal.pone.0099418. eCollection 2014.
9
Cardiac problems in the dialysis patient: beyond coronary disease.透析患者的心脏问题:超越冠状动脉疾病
Semin Dial. 2008 Jul-Aug;21(4):319-25. doi: 10.1111/j.1525-139X.2008.00457.x. Epub 2008 Jul 8.

维持性血液透析的尿毒症患者合并新型冠状病毒肺炎的临床特征

Clinical characteristics of patients with uremia undergoing maintenance hemodialysis complicated with COVID-19.

作者信息

Wang You, Hu Manli, Ye Gang, Zhao Yuanyuan, Yin Qingqiao, Pi Pei, Luo Dan

机构信息

Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei, China.

出版信息

Medicine (Baltimore). 2020 Aug 7;99(32):e21547. doi: 10.1097/MD.0000000000021547.

DOI:10.1097/MD.0000000000021547
PMID:32769892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7593003/
Abstract

This study aimed to evaluate the onset characteristics of patients with uremia undergoing maintenance hemodialysis complicated with COVID-19, so as to improve the understanding, diagnosis, and treatment.26 cases were confirmed cases of COVID-19. Confirmed patients with COVID-19 undergoing maintenance hemodialysis in the blood purification center were recruited. The general data of patients, including age, sex, duration of dialysis, and basic diseases, were analyzed. The clinical features included fever, respiratory symptoms, and gastrointestinal symptoms. The items for laboratory tests included blood routine examination, liver function, C-reactive protein, procalcitonin, creatine kinase, creatine kinase-MB, markers of myocardial injury, B-type natriuretic peptide, D-dimer, and so forth. The imaging examinations referred mainly to computed tomography imaging findings of the lungs.Twenty-one cases were complicated with chronic basic diseases, such as hypertension or diabetes. In terms of clinical manifestations, 13 cases had fever, which was close to the number of cases without fever (13 cases). The respiratory symptoms included dry cough (19 cases), shortness of breath (9 cases), fatigue (11 cases), and so forth. Further, 15 patients had hypoxemia, indicating more severe patients. Sore throat (2 cases) was not significant, and a few patients reported gastrointestinal symptoms (3 cases). The results of blood routine examination showed decreased absolute lymphocyte count (0.7 ± 0.4 × 10∼9/L), lower hemoglobin level (105.2 ± 20 g/L), and normal absolute neutrophil count 4.2 (3.0, 5.9) × 10∼9/L. Of the inflammatory indexes, procalcitonin was 0.69 (0.24, 2.73) ng/mL; C reactive protein was 17.2 (5.2, 181.6) mg/L, which was higher than normal. Blood biochemistry revealed lower albumin level (38.0 ± 4.0 g/L) and higher troponin 0.11(0.035, 6.658) ng/mL and myoglobin levels (538.5 ± 240.5 ng/mL), suggesting myocardial injury.The patients with uremia and confirmed COVID-19 undergoing maintenance hemodialysis are more common in males. Although the proportion of fever patients is 50%, the proportion of hypoxemia patients is high (58%). With poor cardiac function. They were prone to respiratory failure complicated with heart failure. According to the onset characteristics of this population, early diagnosis and treatment could help reduce the risk of developing a critical illness and control the spread of the COVID-19 epidemic.

摘要

本研究旨在评估维持性血液透析合并新型冠状病毒肺炎(COVID-19)的尿毒症患者的发病特征,以提高对其的认识、诊断及治疗水平。26例为COVID-19确诊病例。招募了在血液净化中心接受维持性血液透析的COVID-19确诊患者。分析患者的一般资料,包括年龄、性别、透析时间及基础疾病。临床特征包括发热、呼吸道症状及胃肠道症状。实验室检查项目包括血常规、肝功能、C反应蛋白、降钙素原、肌酸激酶、肌酸激酶同工酶、心肌损伤标志物、B型利钠肽、D-二聚体等。影像学检查主要指肺部计算机断层扫描成像结果。21例合并慢性基础疾病,如高血压或糖尿病。临床表现方面,13例有发热,与无发热病例数相近(13例)。呼吸道症状包括干咳(19例)、气短(9例)、乏力(11例)等。此外,15例患者有低氧血症,提示病情较重。咽痛(2例)不明显,少数患者有胃肠道症状(3例)。血常规检查结果显示淋巴细胞绝对值降低(0.7±0.4×10⁹/L),血红蛋白水平较低(105.2±20g/L),中性粒细胞绝对值正常为4.2(3.0,5.9)×10⁹/L。炎症指标中,降钙素原为0.69(0.24,2.73)ng/mL;C反应蛋白为17.2(5.2,181.6)mg/L,高于正常水平。血液生化检查显示白蛋白水平较低(38.0±4.0g/L),肌钙蛋白为0.11(0.035,6.658)ng/mL,肌红蛋白水平较高(538.5±240.5ng/mL),提示心肌损伤。维持性血液透析的尿毒症合并COVID-19确诊患者男性更为常见。虽然发热患者比例为50%,但低氧血症患者比例较高(58%)。心功能较差。他们易并发呼吸衰竭合并心力衰竭。根据该人群的发病特征,早期诊断和治疗有助于降低危重症发生风险并控制COVID-19疫情传播。